Impaired cardiopulmonary test performance as a marker of early functional impairment in patients with Anderson-Fabry disease

Article Sidebar

Journal of Cardiovascular Medicine and Cardiology volume8-issue4 articles
PDF HTML
Submitted: October 25, 2021
Published: Nov 4, 2021
DOI: 10.17352/2455-2976.000173
Keywords:
Anderson-fabry disease, Exercise, Oxygen consumption, Hypertrophy, Left atrium

Main Article Content

Sergio Caravita*
Istituto Auxologico Italiano, IRCCS, Ospedale San Luca, Milano, Italy
Ilaria Tanini
Department of Experimental and Clinical Medicine, University of Florence, Italy
Lia Crotti
Istituto Auxologico Italiano, IRCCS, Ospedale San Luca, Milano, Italy
Claudia Baratto
Istituto Auxologico Italiano, IRCCS, Ospedale San Luca, Milano, Italy
Gianfranco Parati
Istituto Auxologico Italiano, IRCCS, Ospedale San Luca, Milano, Italy
Francesco Fattirolli
Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy
Iacopo Olivotto
Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy
Franco Cecchi
Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy

Downloads

Download data is not yet available.

Article Details

Caravita, S., Tanini, I., Crotti, L., Baratto, C., Parati, G., Fattirolli, F., Olivotto, I., & Cecchi, F. (2021). Impaired cardiopulmonary test performance as a marker of early functional impairment in patients with Anderson-Fabry disease. Journal of Cardiovascular Medicine and Cardiology, 8(4), 069–071. https://doi.org/10.17352/2455-2976.000173
Short Communications

Copyright (c) 2021 Caravita S, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Nagueh SF (2014) Anderson-Fabry disease and other lysosomal storage disorders. Circulation 130: 1081-1090. Link: https://bit.ly/3mE6Z3e

Spinelli L, Nicolai E, Acampa W, Imbriaco M, Pisani A, et al. (2008) Cardiac performance during exercise in patients with Fabry's disease. Eur J Clin Invest 38: 910-917. Link: https://bit.ly/3q0jc4k

Calcagnino M, O'Mahony C, Coats C, Cardona M, Garcia A, et al. (2011) Exercise-induced left ventricular outflow tract obstruction in symptomatic patients with Anderson-Fabry disease. J Am Coll Cardiol 58: 88-89. Link: https://bit.ly/2ZPZddq

Bierer G, Balfe D, Wilcox WR, Mosenifar Z (2006) Improvement in serial cardiopulmonary exercise testing following enzyme replacement therapy in Fabry disease. J Inherit Metab Dis 29: 572-579. Link: https://bit.ly/3mEcrD4

Wang RY, Lelis A, Mirocha J, Wilcox WR (2007) Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life. Genet Med 9: 34-45. Link: https://bit.ly/2ZL8Que

Lobo T, Morgan J, Bjorksten A, Nicholls K, Grigg L, et al. (2008) Cardiovascular testing in Fabry disease: exercise capacity reduction, chronotropic incompetence and improved anaerobic threshold after enzyme replacement. Intern Med J 38: 407-414. Link: https://bit.ly/3GLYawk

Patel MR, Cecchi F, Cizmarik M, Kantola I, Linhart A, et al. (2011) Cardiovascular events in patients with Fabry disease natural history data from the Fabry registry. J Am Coll Cardiol 57: 1093-1099. Link: https://bit.ly/2ZMRSLK

Tomberli B, Cecchi F, Sciagrà R, Berti V, Lisi F, et al. (2013) Coronary microvascular dysfunction is an early feature of cardiac involvement in patients with Anderson-Fabry disease. Eur J Heart Fail 15: 1363-1373. Link: https://bit.ly/3k0Gof6

Pichette M, Serri K, Pagé M, Di LZ, Bichet DG, et al. (2017) Impaired Left Atrial Function in Fabry Disease: A Longitudinal Speckle-Tracking Echocardiography Study. J Am Soc Echocardiogr 30: 170-179.e2. Link: https://bit.ly/3GHXxDY

Baratto C, Caravita S, Soranna D, Faini A, Dewachter C, et al. (2021) Current Limitations of Invasive Exercise Hemodynamics for the Diagnosis of Heart Failure With Preserved Ejection Fraction. Circ Heart Fail 14: e007555. Link: https://bit.ly/3nQ08TD